Treatment of Refractory Systemic Lupus Erythematosus with iPSC-derived Off-the-Shelf Anti-CD19 CAR T-cell Therapy
Time: 9:30 am
day: Day Two AM
Details:
- Brief review of CAR iT cell (FT819) product configuration and clinical oncology data
- Review of FT819 preclinical and clinical rheumatology data
- Brief overview of CAR iNK cell (FT522) product configuration and rheumatology data
NEW DATA
